Watson issues recall of fentanyl pain patch

CORONA, Calif. Watson Pharmaceuticals has announced that it has recalled about 28,000 units of its fentanyl pain patch. The patches were recalled because it was discovered that their ingredient levels were deviated from specifications, according to a company spokeswoman.

The recall followed a standard six-month stability test on the products while they were on wholesaler and retailer shelves, which found the product to be out of specification, according to Reuters. The type of ingredient that was out of specification was not immediately available.

The fentanyl products were shipped between August and November the recall began in March, at the retail level. The company though believes that most and of the products are now in the hands of customers.

The spokeswoman said the patches were unlikely to pose a health hazard. The lot number involved is 92461681.